Clinical Trial Update: Ivonescimab Plus Chemotherapy in Patients With Initially Unresectable Colorectal Cancer Liver Metastases [Phase 2]

View source ↗

Summary

Phase 2 study evaluating Ivonescimab plus chemotherapy in patients with initially unresectable colorectal cancer liver metastases; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Ivonescimab (AK112/SMT112)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Colorectal Liver Metastases | Phase 2 | Status: RECRUITING